Endonovo Therapeutics Inc (ENDV)

[Craig305]

Let's talk financials.

One of the goals of ENDV is to be uplisted this year. What exchange would be in the realm for them? I see the NASDAQ has a requirement of the bid price to be a minimum of $4.

People here have projected success of the heart clinical to boost SP to the range of $0.85 - $1.30.
This is well short of the $4 min. for Nasdaq.

ENDV will have to settle for another exchange with lower requirements or consider a reverse split to boost the SP. R/S is not necessarily bad. What gives R/S a bad reputation are companies that do that then dilute by increasing # shares and lowering SP again.

Anyone have more information to educate us on the possible realistic scenarios?